Glycobond develops and produces proprietary carbohydrate-binding reagents for use in diagnostics. It is well known that carbohydrate structures that are attached to proteins in the body undergo specific changes during disease processes such as cancer and inflammation. Glycobond uses recombinant technology to produce carbohydrate-binding peptides with defined specificities for use primarily in diagnosis and monitoring of liver disesases and cancer. Our first product is an assay for detecting primary liver cancer at an early stage.
View Top Employees from Glycobond AB| Website | http://www.glycobond.com |
| Revenue | $4 million |
| Employees | View employees |
| Founded | 2011 |
| Address | Teknikringen 1F, Linkoping, OEstergoetland 583 30, SE |
| Phone | +46 72 546 91 10 |
| Technologies |
JavaScript,
HTML,
Twitter
+2 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Medical |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 325413 Companies |
Looking for a particular Glycobond AB employee's phone or email?
Glycobond AB Questions
The Glycobond AB annual revenue was $4 million in 2024.
Glycobond AB is based in Linkoping, OEstergoetland.
The NAICS codes for Glycobond AB are [3254, 32, 325, 32541, 325413].
The SIC codes for Glycobond AB are [283, 28].
